Pfizer has submitted research to the U.S. Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children but the shots may not be available until November.
Sep 29, 2021
0
40
US pharmaceutical company Pfizer said Monday it had begun a clinical trial to test an influenza vaccine designed with the same mRNA technology behind its successful COVID-19 shot.
Sep 28, 2021
0
295
(HealthDay)—Pfizer plans to request approval for use of its COVID-19 vaccine in children under 12 soon.
Sep 27, 2021
0
5
Some 60 million people in the United States are now eligible for a Pfizer booster shot against COVID-19, President Joe Biden said on Friday as a regulatory marathon laying bare divisions within the scientific community on ...
Sep 25, 2021
0
4
The EU's drug watchdog said Thursday it expected to decide in early October whether to approve boosters of the Pfizer/BioNTech COVID-19 vaccine for over 16s.
Sep 23, 2021
0
2
It's shaping up to be a big week for news on two eagerly awaited developments involving Pfizer's COVID-19 vaccine: Booster shots and progress toward its first doses for children as young as five.
Sep 22, 2021
0
18
Pfizer and BioNTech on Monday said trial results showed their coronavirus vaccine is safe and produces a robust immune response in children aged five to 11, adding that they would seek regulatory approval shortly.
Sep 20, 2021
0
1
A new study released by the US Centers for Disease Control and Prevention (CDC) on Friday is the latest to suggest the Moderna Covid vaccine confers better long-term protection against hospitalization than Pfizer.
Sep 17, 2021
0
20
(HealthDay)—Pfizer is expanding the recall of its anti-smoking drug Chantix (varenicline), the company announced Friday.
Sep 17, 2021
0
25
James Cook University scientists have developed a new model to track the COVID pandemic—and it's telling them Australia should now prioritize delivering the Pfizer vaccine to 12-40 year-olds.
Sep 6, 2021
3
17
